Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
The Lancet. Global Health|March 28, 2025
A roadmap for fostering timely regulatory and ethics approvals of international clinical trials in support of global health research systemsMarco Cavaleri, Claudiosvam M Alves de Sousa, Adam Hacker, et al.
Pharmacology Research & Perspectives|July 20, 2022
Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine-artesunate in a rural health district in Burkina FasoToussaint Rouamba, Paul Sondo, Isidore W Yerbanga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2016
Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in GhanaGeorge Armah, Kimberly Pringle, Christabel C Enweronu-Laryea, et al.
BMJ Open|May 21, 2025
Menstrual health needs and educational outcomes among adolescent girls living in countries in sub-Saharan Africa: systematic review protocolSitsofe Gbogbo, Wisdom Kudzo Axame, Israel Wuresah, et al.
Patient Preference and Adherence|March 19, 2019
High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina FasoToussaint Rouamba, Paul Sondo, Isidore W Yerbanga, et al.
The Journal of Nutrition, Health & Aging|May 15, 2025
Enhancing the methodology of clinical trials in older people: A scoping review with global perspectiveMatteo Cesari, Marco Canevelli, Wei Zhang, et al.
Bulletin of the World Health Organization|April 4, 2006
Cause-specific mortality rates in sub-Saharan Africa and BangladeshMartin Adjuik, Tom Smith, Sam Clark, et al.
Journal of Medical Ethics|February 6, 2010
The use of placebo in a trial of rectal artesunate as initial treatment for severe malaria patients en route to referral clinics: ethical issuesAndrew Kitua, Peter Folb, Marian Warsame, et al.
Vaccine|January 27, 2018
Rotavirus strain distribution in Ghana pre- and post- rotavirus vaccine introductionBelinda L Lartey, Susan Damanka, Francis Ekow Dennis, et al.
The Lancet. Infectious Diseases|August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialAngela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
Pageof 8